Mission BioCapital
Overview
Mission BioCapital is a life science venture capital firm that invests in early-stage companies.
Investment Focus
- Early-stage life sciences companies with transformative technologies in therapeutics, diagnostics, medical devices, and drug delivery.
Portfolio Companies
Get the full list of 54,000+ investors
Mission BioCapital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Mission BioCapital
What sectors does Mission BioCapital invest in?
Mission BioCapital invests in Healthcare, Life Sciences, Medical Devices, Diagnostics, Biotechnology and Drug Delivery, and is based in Cambridge, United States. Mission BioCapital is listed as a vc in the ConnectSafely investor database.
What stage does Mission BioCapital invest at?
Mission BioCapital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 250K - 500K.
Which regions does Mission BioCapital invest in?
Mission BioCapital invests across United States, Germany and Denmark.
Who are the partners at Mission BioCapital?
Team members listed for Mission BioCapital include Chris Carlin (Chief Operations Officer and Chief Compliance Oficer) and Peter Parker (Managing General Partner).
What companies has Mission BioCapital invested in?
Mission BioCapital's portfolio includes Aperture Therapeutics, D2B3, ImmunOs Therapeutics AG and Nuvig Therapeutics.
How do I contact Mission BioCapital?
Mission BioCapital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
